Additionally, we tested additional human bladder cancer cells with wild-type Ras genes (RT112, 253J B-V, TCCSUP) and found that these cell lines without Kras/Hras/Nras mutation were always relatively resistant to FL118 treatment (Figure S1, Table 1). The gene discussed is HRAS; the disease is urinary bladder carcinoma.